 |
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
1eub
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Solution structure of the catalytic domain of human collagenase-3 (mmp-13) complexed to a potent non-peptidic sulfonamide inhibitor
|
|
Structure:
|
 |
Collagenase 3. Chain: a. Fragment: catalytic domain. Synonym: matrix metalloproteinase-13, mmp-13. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
NMR struc:
|
 |
20 models
|
 |
|
Authors:
|
 |
X.Zhang,N.C.Gonnella,J.Koehn,N.Pathak,V.Ganu,R.Melton, D.Parker,S.I.Hu,K.Y.Nam
|
Key ref:
|
 |
X.Zhang
et al.
(2000).
Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
J Mol Biol,
301,
513-524.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
14-Apr-00
|
Release date:
|
14-Apr-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P45452
(MMP13_HUMAN) -
Collagenase 3
|
|
|
|
Seq: Struc:
|
 |
 |
 |
471 a.a.
171 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular matrix
|
1 term
|
 |
|
Biological process
|
proteolysis
|
1 term
|
 |
|
Biochemical function
|
metallopeptidase activity
|
3 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
301:513-524
(2000)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1.
|
|
X.Zhang,
N.C.Gonnella,
J.Koehn,
N.Pathak,
V.Ganu,
R.Melton,
D.Parker,
S.I.Hu,
K.Y.Nam.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The full three-dimensional structure of the catalytic domain of human
collagenase-3 (MMP-13) complexed to a potent, sulfonamide hydroxamic acid
inhibitor (CGS 27023) has been determined by NMR spectroscopy. The results
reveal a core domain for the protein consisting of three alpha-helices and five
beta-sheet strands with an overall tertiary fold similar to the catalytic
domains of other matrix metalloproteinase family members. The S1' pocket, which
is the major site of hydrophobic binding interaction, was found to be a wide
cleft spanning the length of the protein and presenting facile opportunity for
inhibitor extension deep into the pocket. Comparison with the reported X-ray
structure of collagenase-3 showed evidence of flexibility for the loop region
flanking the S1' pocket in both NMR and X-ray data. This flexibility was
corroborated by NMR dynamics studies. Inhibitor binding placed the methoxy
phenyl ring in the S1' pocket with the remainder of the molecule primarily
solvent-exposed. The binding mode for this inhibitor was found to be similar
with respect to stromelysin-1 and collagenase-1; however, subtle comparative
differences in the interactions between inhibitor and enzyme were observed for
the three MMPs that were consistent with their respective binding potencies.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. Full 3D structure of the catalytic domain of
human collagenase-3 complexed to CGS 27023. The enzyme backbone
is shown in blue, antiparallel strand b4 in yellow and the
inhibitor is shown in red. Zinc and calcium atoms appear as
purple and gray spheres, respectively. Bi-dentate coordination
with the catalytic zinc and hydrogen bonding interactions
between the inhibitor's sulfonamide oxygen atoms and Leu185 [HN]
and the inhibitor's 1HN and the carbonyl oxygen atom of Ala186
are displayed as white dotted lines. The relative orientation of
S1' (extending into the plane of the page), S2' and S (opposite
direction to S1') are displayed. The phenyl ring (pink) from
Tyr214 forms a favorable perpendicular interaction with methoxy
phenyl ring of the inhibitor.
|
 |
Figure 5.
Figure 5. Active site of the collagenase-3-CGS 27023
complex. The inhibitor is displayed as a liquorice model. The
NOEs defining the eclipsed orientation of the inhibitor's
isopropyl group with its pyridine ring are shown as yellow
dotted lines. The enzyme solid surface, generated with the GRASP
program [Nicholls et al 1991], shows positive and negative
charged surfaces as blue and red patches, respectively.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2000,
301,
513-524)
copyright 2000.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
J.D.Durrant,
C.A.de Oliveira,
and
J.A.McCammon
(2010).
Including receptor flexibility and induced fit effects into the design of MMP-2 inhibitors.
|
| |
J Mol Recognit, 23,
173-182.
|
 |
|
|
|
|
 |
A.R.Johnson,
A.G.Pavlovsky,
D.F.Ortwine,
F.Prior,
C.F.Man,
D.A.Bornemeier,
C.A.Banotai,
W.T.Mueller,
P.McConnell,
C.Yan,
V.Baragi,
C.Lesch,
W.H.Roark,
M.Wilson,
K.Datta,
R.Guzman,
H.K.Han,
and
R.D.Dyer
(2007).
Discovery and characterization of a novel inhibitor of matrix metalloprotease-13 that reduces cartilage damage in vivo without joint fibroplasia side effects.
|
| |
J Biol Chem, 282,
27781-27791.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.A.Alcaraz,
L.Banci,
I.Bertini,
F.Cantini,
A.Donaire,
and
L.Gonnelli
(2007).
Matrix metalloproteinase-inhibitor interaction: the solution structure of the catalytic domain of human matrix metalloproteinase-3 with different inhibitors.
|
| |
J Biol Inorg Chem, 12,
1197-1206.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Bertini,
V.Calderone,
M.Cosenza,
M.Fragai,
Y.M.Lee,
C.Luchinat,
S.Mangani,
B.Terni,
and
P.Turano
(2005).
Conformational variability of matrix metalloproteinases: beyond a single 3D structure.
|
| |
Proc Natl Acad Sci U S A, 102,
5334-5339.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Svab,
D.Alexandru,
G.Vitos,
and
M.L.Flonta
(2004).
Binding affinities for sulfonamide inhibitors with matrix metalloproteinase-2 using a linear response method.
|
| |
J Cell Mol Med, 8,
551-562.
|
 |
|
|
|
|
 |
V.Lukacova,
Y.Zhang,
M.Mackov,
P.Baricic,
S.Raha,
J.A.Calvo,
and
S.Balaz
(2004).
Similarity of binding sites of human matrix metalloproteinases.
|
| |
J Biol Chem, 279,
14194-14200.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|